Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
COSM 
Cosmos Health Inc. (COSM)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: COSM (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Year Target Price $3
Year Target Price $3
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Under performing |
| 0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit -33.42% | Avg. Invested days 27 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 12.48M USD | Price to earnings Ratio - | 1Y Target Price 3 |
Price to earnings Ratio - | 1Y Target Price 3 | ||
Volume (30-day avg) - | Beta 4.21 | 52 Weeks Range 0.28 - 1.58 | Updated Date 06/29/2025 |
52 Weeks Range 0.28 - 1.58 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.09 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -28.26% | Operating Margin (TTM) -6.08% |
Management Effectiveness
Return on Assets (TTM) -14.9% | Return on Equity (TTM) -50.03% |
Valuation
Trailing PE - | Forward PE 52.63 | Enterprise Value 24394864 | Price to Sales(TTM) 0.23 |
Enterprise Value 24394864 | Price to Sales(TTM) 0.23 | ||
Enterprise Value to Revenue 0.46 | Enterprise Value to EBITDA -1.6 | Shares Outstanding 29241700 | Shares Floating 17810378 |
Shares Outstanding 29241700 | Shares Floating 17810378 | ||
Percent Insiders 31.08 | Percent Institutions 9.46 |
Analyst Ratings
Rating 4 | Target Price 3 | Buy 1 | Strong Buy - |
Buy 1 | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Cosmos Health Inc.
Company Overview
History and Background
Cosmos Health Inc., formerly known as PolarityTE, Inc., is a global healthcare group that was founded in 2009. It originally focused on regenerative medicine, but has since pivoted to a broader range of healthcare and wellness products and services, including pharmaceutical and medical device distribution, own branded and third-party branded products, and e-commerce.
Core Business Areas
- Pharmaceutical and Medical Device Distribution: This segment involves the distribution of generic and branded pharmaceutical products, medical devices, and other healthcare products to pharmacies, hospitals, and other healthcare providers.
- Own Branded and Third-Party Branded Products: This segment focuses on the development, manufacturing, and marketing of its own branded healthcare and wellness products, as well as the distribution of third-party branded products.
- E-Commerce: Cosmos Health operates an e-commerce platform that sells its products directly to consumers.
Leadership and Structure
The leadership team includes individuals in positions such as CEO, CFO, and other key executives. The organizational structure likely includes departments for sales, marketing, operations, finance, and research and development.
Top Products and Market Share
Key Offerings
- Pharmaceutical Products: Cosmos Health distributes generic and branded pharmaceutical products. Market share data is difficult to ascertain for specific distributed products due to the broad nature of the market. Competitors include McKesson, Cardinal Health, and AmerisourceBergen.
- Medical Devices: The company distributes medical devices. Market share data is not publicly available. Competitors include Medtronic, Johnson & Johnson, and Stryker.
- Branded Products (Nutraceuticals, etc.): Cosmos Health offers its own branded line of health and wellness products. Market share information is limited for its specific branded products. The nutraceutical market is highly competitive with companies such as Nestle Health Science, Abbott, and Amway.
Market Dynamics
Industry Overview
The healthcare industry is characterized by high growth, driven by an aging population, increasing prevalence of chronic diseases, and technological advancements. The pharmaceutical and medical device distribution market is highly competitive and regulated.
Positioning
Cosmos Health is positioned as a diversified healthcare company with a focus on pharmaceutical distribution, branded products, and e-commerce. Its competitive advantages include its distribution network and its portfolio of branded products.
Total Addressable Market (TAM)
The global healthcare market is estimated to be in the trillions of dollars. Cosmos Health's positioning allows it to capture a portion of this large TAM. Given the focus on pharmaceuticals, medical devices, and wellness products, the relevant TAM is likely several hundred billion dollars. Cosmos Health's current market share is very small compared to the overall TAM.
Upturn SWOT Analysis
Strengths
- Diversified business model
- Distribution network
- Portfolio of branded products
- E-commerce platform
Weaknesses
- Limited financial resources
- Relatively small market share in competitive markets
- Past history as PolarityTE, Inc. and prior focus on regenerative medicine which may still affect public perception
- Dependence on third-party suppliers
Opportunities
- Expanding its product portfolio
- Growing its e-commerce sales
- Acquiring other healthcare companies
- Entering new markets
Threats
- Increased competition
- Changes in healthcare regulations
- Economic downturn
- Product liability lawsuits
Competitors and Market Share
Key Competitors
- MCK
- CAH
- ABC
Competitive Landscape
Cosmos Health faces intense competition from larger, more established players. Its advantages include its focus on niche markets and its ability to offer customized solutions. However, it needs to differentiate itself further to compete effectively.
Major Acquisitions
Pharmasyn
- Year: 2022
- Acquisition Price (USD millions): 4.2
- Strategic Rationale: To increase Cosmos Healthu2019s access to generic pharmaceuticals in Europe and gain commercial synergies.
Growth Trajectory and Initiatives
Historical Growth: Cosmos Health's growth has been volatile, with significant changes in its business model.
Future Projections: Future growth projections are uncertain and depend on the company's ability to execute its business strategy. Analyst estimates may vary widely. Further financial data is required.
Recent Initiatives: Recent initiatives include expanding its e-commerce platform, launching new branded products, and pursuing strategic acquisitions.
Summary
Cosmos Health Inc. is a small, diversified healthcare company facing intense competition from much larger players. While it has strengths in its distribution network and branded products, it needs to improve its financial performance and differentiate itself further to achieve sustainable growth. Its history as PolarityTE, Inc. and pivot away from regenerative medicine adds a layer of complexity to its brand perception. Strategic acquisitions like Pharmasyn are positive steps, but overall execution is key for success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Market Research Reports
- Press Releases
- Company Website
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute financial advice. Investment decisions should be made based on individual circumstances and consultation with a qualified financial advisor. Market share data might not be precise and is sourced from diverse and sometimes inconsistent sources.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cosmos Health Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 2012-10-11 | Chairman & CEO Mr. Grigorios Siokas | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 149 | |
Full time employees 149 | |||
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus. The company offers medicines, OTC medicines, nutraceutical products, vitamins, minerals, and dietary health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names. Other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag to promote peaceful sleep; Otikon ear drops, which is a Class II medical device in the form of ear drops; and Bio-bebe, an organic infant care and nutrition brand. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies, and independent specialty distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.